Effect of Lopinavir/ritonavir (LPV/r) and Atazanavir/ritonavir (ATV/r) in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates

Trial Profile

Effect of Lopinavir/ritonavir (LPV/r) and Atazanavir/ritonavir (ATV/r) in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Atazanavir/ritonavir (Primary) ; Lopinavir/ritonavir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top